261 related articles for article (PubMed ID: 24004055)
1. The role of sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) in regulation of osteoclastic and osteoblastic cells.
Dziak R
Immunol Invest; 2013; 42(7):510-8. PubMed ID: 24004055
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid and sphingosine 1-phosphate metabolic pathways and their receptors are differentially regulated during decidualization of human endometrial stromal cells.
Brünnert D; Sztachelska M; Bornkessel F; Treder N; Wolczynski S; Goyal P; Zygmunt M
Mol Hum Reprod; 2014 Oct; 20(10):1016-25. PubMed ID: 24994816
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.
Brizuela L; Martin C; Jeannot P; Ader I; Gstalder C; Andrieu G; Bocquet M; Laffosse JM; Gomez-Brouchet A; Malavaud B; Sabbadini RA; Cuvillier O
Mol Oncol; 2014 Oct; 8(7):1181-95. PubMed ID: 24768038
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
[TBL] [Abstract][Full Text] [Related]
5. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis.
Pyne NJ; Dubois G; Pyne S
Biochim Biophys Acta; 2013 Jan; 1831(1):228-38. PubMed ID: 22801038
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential.
Meshcheryakova A; Mechtcheriakova D; Pietschmann P
Expert Opin Ther Targets; 2017 Jul; 21(7):725-737. PubMed ID: 28524744
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone.
Sims SM; Panupinthu N; Lapierre DM; Pereverzev A; Dixon SJ
Biochim Biophys Acta; 2013 Jan; 1831(1):109-16. PubMed ID: 22892679
[TBL] [Abstract][Full Text] [Related]
8. Cell surface receptors in lysophospholipid signaling.
Anliker B; Chun J
Semin Cell Dev Biol; 2004 Oct; 15(5):457-65. PubMed ID: 15271291
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.
Rosen H; Goetzl EJ
Nat Rev Immunol; 2005 Jul; 5(7):560-70. PubMed ID: 15999095
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate (S1P) receptors: Promising drug targets for treating bone-related diseases.
Zhang L; Dong Y; Wang Y; Hu W; Dong S; Chen Y
J Cell Mol Med; 2020 Apr; 24(8):4389-4401. PubMed ID: 32155312
[TBL] [Abstract][Full Text] [Related]
11. Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms.
Boucharaba A; Guillet B; Menaa F; Hneino M; van Wijnen AJ; Clézardin P; Peyruchaud O
Oncol Res; 2009; 18(4):173-84. PubMed ID: 20112503
[TBL] [Abstract][Full Text] [Related]
12. Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.
Shea BS; Tager AM
Proc Am Thorac Soc; 2012 Jul; 9(3):102-10. PubMed ID: 22802282
[TBL] [Abstract][Full Text] [Related]
13. New insights into the role of sphingosine 1-phosphate and lysophosphatidic acid in the regulation of skeletal muscle cell biology.
Donati C; Cencetti F; Bruni P
Biochim Biophys Acta; 2013 Jan; 1831(1):176-84. PubMed ID: 22877992
[TBL] [Abstract][Full Text] [Related]
14. Lysophospholipids enhance taurine release from rat retinal vascular endothelial cells under hypoosmotic stress.
Tachikawa M; Tsuji K; Ikeda S; Hosoya K
Microvasc Res; 2009 Dec; 78(3):332-7. PubMed ID: 19804786
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.
Sartawi Z; Schipani E; Ryan KB; Waeber C
Pharmacol Res; 2017 Nov; 125(Pt B):232-245. PubMed ID: 28855094
[TBL] [Abstract][Full Text] [Related]
16. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer.
Peyruchaud O
Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039
[TBL] [Abstract][Full Text] [Related]
17. Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate.
Grey A; Xu X; Hill B; Watson M; Callon K; Reid IR; Cornish J
Calcif Tissue Int; 2004 Jun; 74(6):542-50. PubMed ID: 15354862
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells.
Itoh R; Miura S; Takimoto A; Kondo S; Sano H; Hiraki Y
J Bone Miner Metab; 2010 Nov; 28(6):659-71. PubMed ID: 20458606
[TBL] [Abstract][Full Text] [Related]
19. A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay.
Fleming JK; Glass TR; Lackie SJ; Wojciak JM
J Lipid Res; 2016 Sep; 57(9):1737-47. PubMed ID: 27444045
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor.
Holdsworth G; Osborne DA; Pham TT; Fells JI; Hutchinson G; Milligan G; Parrill AL
BMC Biochem; 2004 Aug; 5():12. PubMed ID: 15298705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
